Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

On Thursday, Soligenix Inc. (NASDAQ:SNGX) opened patient enrollment for its DUS-AUBD-01 Phase 2 study evaluating SGX945 ...

COVID-19 was significantly associated with an increased risk for alopecia areata, alopecia totalis, vitiligo, Behçet disease, Crohn disease, ulcerative colitis, rheumatoid arthritis, systemic lupus ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet ...

29 Oct - ANGERME member Yuki Hirayama recently revealed that she has been diagnosed with the rare disease called Behcet's ...

Choosing the appropriate legal structure for your business may be confusing for new entrepreneurs, with each option having its own advantages and disadvantages. Adding to that confusion is the ...

Behcet's and Reiter's syndrome may have ocular and genital lesions that can be confused with those seen in SJS. The diagnosis is made when the characteristic rash appears 1 to 3 weeks after ...